LOADING
Liver conditions, particularly hepatitis C and cirrhosis, have been a significant source of disability among American veterans for decades. Vietnam-era veterans have particularly high rates of hepatitis C due to a combination of factors including combat blood exposure, air gun immunizations, and other blood-borne transmission routes. Post-9/11 veterans face risks from deployment exposures and medical interventions. Under 38 CFR 4.114, the VA rates liver conditions with specific criteria for viral hepatitis, cirrhosis, liver cancer, and transplant.
Hepatitis C is rated under Diagnostic Code 7345 (Chronic liver disease without cirrhosis) per the May 19, 2024 § 4.114 amendment. DC 7354 is now reduced to a single-line pointer stating "Rate under DC 7345." The current 5-tier schedule has no 10 percent rating. A 0 percent rating applies for previous history of liver disease, currently asymptomatic (this includes post-SVR patients with no residuals after successful direct-acting antiviral therapy). A 20 percent rating applies when there is chronic liver disease with at least one of the following five symptoms: intermittent fatigue, malaise, anorexia, hepatomegaly, or pruritus. A 40 percent rating applies for progressive chronic liver disease requiring continuous medication AND causing minor weight loss AND at least two of six symptoms (daily fatigue, malaise, anorexia, hepatomegaly, pruritus, arthralgia). A 60 percent rating applies for the same criteria but with substantial weight loss. A 100 percent rating requires progressive chronic liver disease that requires BOTH parenteral antiviral therapy (direct antiviral agents) AND parenteral immunomodulatory therapy (interferon and other), continuing for six months following discontinuance. Critically: modern oral direct-acting antivirals like Harvoni, Sovaldi, Epclusa, and Mavyret are NOT parenteral and do not by themselves trigger the 100 percent tier even when they achieve sustained virologic response (SVR / cure). Cirrhosis sequelae rate separately under DC 7312, and hepatocellular carcinoma under DC 7343, per Note (4) anti-pyramiding principles.
The concept of incapacitating episodes is defined as a period of acute signs and symptoms severe enough to require bed rest and treatment by a physician. Documentation of such episodes, including medical records showing physician-directed bed rest, supports the higher rating tiers.
Cirrhosis is rated under DC 7312. A 10 percent rating applies for symptoms such as weakness, anorexia, abdominal pain, and malaise. A 30 percent rating applies for portal hypertension and splenomegaly, with weakness, anorexia, abdominal pain, malaise, and at least minor weight loss. A 50 percent rating applies for a history of one episode of ascites, hepatic encephalopathy, or hemorrhage from varices or portal gastropathy (erosive gastritis). A 70 percent rating applies for a history of two or more episodes of ascites, hepatic encephalopathy, or hemorrhage from varices or portal gastropathy, but with periods of remission between attacks. A 100 percent rating applies for generalized weakness, substantial weight loss, and persistent jaundice, or with one of the following refractory to treatment: ascites, hepatic encephalopathy, hemorrhage from varices or portal gastropathy.
Liver cancer is rated at 100 percent during active treatment under DC 7343 or the applicable cancer code, with residuals rated after treatment based on any ongoing liver dysfunction. Liver transplant is rated at 100 percent for a minimum of one year post-transplant under DC 7351, with residuals rated thereafter.
Service connection for hepatitis C in Vietnam-era veterans has been strongly supported by research showing elevated rates in this population. The VA has recognized air gun immunization as a potential transmission route, as jet injectors used before the mid-1990s were not always thoroughly sterilized between uses. Combat blood exposure, blood transfusions before widespread hepatitis C screening, tattoos obtained from non-sterile equipment, and certain medical procedures can all support a direct service connection claim.
The VA has not designated hepatitis C as a presumptive condition for any service era, meaning each claim must establish a nexus between the infection and service events. A well-supported nexus letter from an infectious disease specialist or hepatologist is typically the key evidence. The letter should address the specific risk factors during service that support the conclusion that the infection was at least as likely as not contracted during military service.
Treatment for hepatitis C has advanced dramatically with the availability of direct-acting antiviral medications, which cure most cases within a few months of treatment. Veterans who successfully complete treatment may still have residual liver damage including fibrosis or cirrhosis. The rating then reflects the residual liver condition rather than active hepatitis. This is a legitimate pathway for ongoing ratings after hepatitis C has been effectively treated.
Evidence for a liver disease claim includes service treatment records, records of any blood exposures during service including combat injuries, immunization records showing air gun use, current medical records with gastroenterology or hepatology consultations, liver function laboratory values, imaging such as liver ultrasound, CT, MRI, or FibroScan, biopsy results if performed, and a nexus letter for direct service connection claims.
The C&P exam for liver conditions includes a focused history, physical examination assessing liver size, signs of cirrhosis, and nutritional status, review of laboratory values, and completion of the liver conditions DBQ. Describe incapacitating episodes specifically, including their duration, treatment required, and impact on work and daily life. List all symptoms including fatigue, nausea, abdominal discomfort, jaundice episodes, and weight changes.
Secondary considerations for liver conditions include diabetes, which can develop from cirrhosis-related hepatic insulin resistance, and cryoglobulinemia, kidney disease, and other extrahepatic manifestations of hepatitis C. Each can be claimed as secondary with appropriate evidence.
The ClaimRecon Rating Calculator models how liver condition ratings combine with your other service-connected conditions. The C&P Exam Simulator walks through the liver conditions DBQ questions including incapacitating episodes and complication history. The Secondary Condition Finder maps liver disease to its common complications and co-occurring conditions. The Personal Statement Builder helps you document the episodic and cumulative impact of chronic liver disease.
Disclaimer: This article is for educational and informational purposes only. It does not constitute legal, medical, or VA claims advice. Liver condition rating criteria under 38 CFR 4.114 are subject to change. Always verify current criteria at VA.gov or consult with an accredited VSO, attorney, or claims agent before making decisions about your benefits.
Written by ClaimRecon Editorial